Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. bariatric
Show results for
Products
Services
Software
Applications

Companies

News
Articles
Books
Downloads
Videos

Refine by
Date

  • Older

Bariatric Articles & Analysis

16 news found

Ezisurg Medical presented at the European Bariatric Endoscopic Surgery Congress

Ezisurg Medical presented at the European Bariatric Endoscopic Surgery Congress

On 23-24th September, 2021, the annual European Bariatric Endoscopic Surgery Trends (BEST) was successfully held in Montpellier, France. The BEST congress adopted a unique mode of online and offline access, bringing global experts and scholars together to discuss the cutting-edge progress in the field of bariatric surgery. Ezisurg Medical was honored to become ...

ByEzisurg Medical Co., Ltd.


ReShape Lifesciences Announces 2017 Weight Loss Contest Winner

ReShape Lifesciences Announces 2017 Weight Loss Contest Winner

Vivek Kumbhari, MD, Director of Endoscopy at Johns Hopkins Bayview Medical Center & Director of Bariatric Endoscopy at Johns Hopkins Weight Management Center. The second and third place winners, a 39-year-old male and a 33-year-old female, had 6-month TWL of 25% and 21%, respectively. ...

ByReShape Lifesciences Inc.


ReShape Lifesciences Receives FDA 510(k) Clearance for the GIBI HD Calibration Tubes for use in Gastric and Bariatric Procedures

ReShape Lifesciences Receives FDA 510(k) Clearance for the GIBI HD Calibration Tubes for use in Gastric and Bariatric Procedures

Food and Drug Administration (FDA) 510(k) clearance for the disposable, Gastro Intestinal Balloon Indicator (GIBI HD™) calibration tube for use in gastric and bariatric surgical procedures. The company expects U.S. commercial sales to begin in September 2022. The GIBI HD™ includes three new sizes – 32, 36, and 40 Fr – all designed to simplify ...

ByReShape Lifesciences Inc.


GI Dynamics Announces Final Data from the ENDO Trial, a Multicenter Study Demonstrating the Potential Use of EndoBarrier to Treat Type II Diabetes and Obesity.

GI Dynamics Announces Final Data from the ENDO Trial, a Multicenter Study Demonstrating the Potential Use of EndoBarrier to Treat Type II Diabetes and Obesity.

“Insulin therapy is associated with poor long-term outcomes in patients with type 2 diabetes mellitus and obesity, and bariatric surgery is effective for glycemic control but is higher risk than medical therapy. ...

ByGI Dynamics, Inc.


Activ Surgical Successfully Completes Institutional Review Board Study at University at Buffalo

Activ Surgical Successfully Completes Institutional Review Board Study at University at Buffalo

Christina Sanders, medical director of ECMC Synergy Bariatrics for UB, and demonstrated how the FDA-cleared ActivSight imaging module can provide real time, on-demand insights and intraoperative visual data and images not currently available to surgeons through existing technologies. ...

ByActiv Surgical, Inc.


Altimmune Announces Initiation Of 48-Week Phase 2 MOMENTUM Trial Of Pemvidutide In Obesity

Altimmune Announces Initiation Of 48-Week Phase 2 MOMENTUM Trial Of Pemvidutide In Obesity

If these effects continue over the 48-week study as anticipated, weight loss approaching or equaling those of bariatric surgery may be achieved. Side effects were mild to moderate, with no serious or severe treatment-emergent adverse events, even without the dose-titration schedules commonly used by other therapeutics in this class. ...

ByAltimmune Inc.


CMR Surgical & Surgical Innovations develop new surgical hybrid port access system

CMR Surgical & Surgical Innovations develop new surgical hybrid port access system

Elemental also has exclusive UK distribution for a select group of specialist products employed in Laparoscopy, Bariatric and Metabolic, Hernia Repair and Breast Reconstruction surgery. ...

BySurgical Innovations Limited


Fractyl Health Provides Initial Clinical Update on Open-Label REVITA-T2Di

Fractyl Health Provides Initial Clinical Update on Open-Label REVITA-T2Di

“We are thrilled to be participating as a leading center in the Revitalize T2D program,” said Carlos Galvani, M.D., Professor and Chief Division of Minimally Invasive Bariatric Surgery at Tulane University. “We are encouraged by our initial clinical experience with Revita in our patients and look forward to longer-term outcomes as well as our efforts in the ...

ByFractyl Health


Asensus Surgical Provides Preliminary 2021 Year-End Corporate Update

Asensus Surgical Provides Preliminary 2021 Year-End Corporate Update

These procedures included general surgery, gynecology, urology, colorectal, pediatric, and bariatric surgical cases. Clinical Validation During 2021, there were 21 peer-reviewed clinical papers published providing further support for the clinical utility of the Senhance System across a variety of surgical specialties. ...

ByAsensus Surgical US, Inc.


How virtually `scrubbing in` could help surgeons hone their skills

How virtually `scrubbing in` could help surgeons hone their skills

Dr. Santiago Horgan, general and bariatric surgeon, and chief of minimally invasive surgery at the University of California San Diego, performed the surgery using the combined system. ...

ByProximie Limited


Activ Surgical Completes First In-Human Procedures to Demonstrate Impact of its Surgical Intelligence and Sensing Platform

Activ Surgical Completes First In-Human Procedures to Demonstrate Impact of its Surgical Intelligence and Sensing Platform

Erik Wilson, professor in the Department of Surgery at McGovern Medical School at UTHealth and a leading bariatric, endoluminal and robotic general surgeon; and Dr. Shinil Shah, associate professor at UTHealth Houston and a preeminent general surgeon with expertise in advanced gastrointestinal surgery. The safety and feasibility study was conducted across ...

ByActiv Surgical, Inc.


ReShape Lifesciences Receives USPTO Issue Notification for Patent Covering its ReShape Vest

ReShape Lifesciences Receives USPTO Issue Notification for Patent Covering its ReShape Vest

The ReShape Vest, a new investigational medical device for weight loss in obese patients, wraps around the stomach and is designed to emulate conventional bariatric surgery without permanent anatomical changes. The ReShape Vest can be implanted in a minimally-invasive procedure with a goal to control weight gain and obesity. ...

ByReShape Lifesciences Inc.


ReShape Lifesciences Technologies to be Featured at Minimally Invasive Surgery Symposium

ReShape Lifesciences Technologies to be Featured at Minimally Invasive Surgery Symposium

(NASDAQ:RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, announced today that the Company and its products will be discussed during the Metabolic and Bariatric Sessions of the Minimally Invasive Surgery Symposium (MISS) taking place in Las Vegas from March 6-9, 2018. Details of the presentations are as follows: Friday, March 9, ...

ByReShape Lifesciences Inc.


ReShape Lifesciences Announces Stocking Order from Medical Supplier in Dubai

ReShape Lifesciences Announces Stocking Order from Medical Supplier in Dubai

This order, the second since Al Zawhari’s initial stocking order in August 2017, is to support increased demand for the Reshape Integrated Dual Balloon System from a leading hospital customer’s growing bariatric program in Dubai. Obesity in the UAE has been estimated to be twice the worldwide rate. ...

ByReShape Lifesciences Inc.


Blue Chip Medical Appoints Dorian Drake International as its Export Representative for Latin America and the Caribbean

Blue Chip Medical Appoints Dorian Drake International as its Export Representative for Latin America and the Caribbean

Based out of its corporate headquarters and manufacturing plant in Suffern, NY, Blue Chip offers a solution for every type of patient: adult, pediatric, geriatric or bariatric. All products can be customized for a patient’s size and weight. ...

ByDorian Drake International


ReShape Medical, Inc. Completes $38 Million Series D Financing

ReShape Medical, Inc. Completes $38 Million Series D Financing

The ReShape Procedure provides a non-surgical option for adults with a BMI of 30-40 and a related health condition who haven’t succeeded at diet and exercise alone, and do not want or do not qualify for bariatric surgery. The new capital will be used to support U.S. commercialization of the ReShape Integrated Dual Balloon System. ...

ByReShape Lifesciences Inc.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT